Pasithea Therapeutics Corp (KTTA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $17.44M
Last updated: Nov 17, 2026 at 4:10 PM ET
Pasithea Therapeutics Corp (KTTA) Stock Chart
Pasithea Therapeutics (KTTA) has a latest price of $0.43 on Nov 17, 2026, 78.9% below its 52-week high of $2.06. Its price fell 39.5% over the past 12 months. The month-end price fell 99.3% over the 5 years through Oct 2026, a compound annual decline of 63.4%.
Price Chart
From Sep 2021 to Oct 2026, its highest month-end close was $72.20 in Nov 2021 and its lowest $0.37 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart KTTA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for KTTA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 11.4%, and over 6 months it fell 38.2%. The month-end price fell 94.7% over the 3 years through Oct 2026, a compound annual decline of 62.5%.
| Period | Change |
|---|---|
| 1 month | +5.3% |
| 3 months | -11.4% |
| 6 months | -38.2% |
| 12 months | -39.5% |
| 12 months, with dividends | -39.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -94.7% | -62.5% |
| 5 years | -99.3% | -63.4% |
Price by Year
Its best calendar year was 2023, when the price fell 42.3%, and its weakest was 2022, when it fell 63.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.37 | -71.3% |
| 2025 | $1.29 | -59.0% |
| 2024 | $3.15 | -57.4% |
| 2023 | $7.40 | -42.3% |
| 2022 | $12.83 | -63.7% |
Trading Range
The price is 8.6% below its 50-day average of $0.48 and 28.8% below its 200-day average of $0.61.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.43 | |
| 52-week high | $2.06 | -78.9% |
| 52-week low | $0.28 | +54.6% |
| 50-day average | $0.48 | -8.6% |
| 200-day average | $0.61 | -28.8% |
Price Risk
Over 3 years, its largest fall from a peak was 96.8%.
| Measure | Value |
|---|---|
| 1-year beta | 1.15 |
| Largest fall, 1 year | -75.0% |
| Largest fall, 3 years | -96.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About KTTA
What is KTTA's 1-year price change?
Pasithea Therapeutics's price fell 39.5% over the past 12 months. With dividends included, the 12-month total return was -39.5%.
What is KTTA's 5-year price change?
Pasithea Therapeutics's month-end price fell 99.3% over the 5 years through Oct 2026, a compound annual decline of 63.4%. These figures leave out dividends.
What is KTTA's 52-week high and low?
Pasithea Therapeutics's 52-week high is $2.06 and its 52-week low is $0.28. Its latest price of $0.43 on Nov 17, 2026 is 78.9% below the high.
What is KTTA's beta?
Pasithea Therapeutics's 1-year beta against the S&P 500 is 1.15, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 75.0%.
Is the KTTA chart free?
Yes. Advanced Charting for KTTA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
KTTA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors